Azstarys

Azstarys

Azstarys

Serdexmethylphenidate and Dexmethylphenidate

Capsules: 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg

KemPharm, Inc.

Medical Use

Azstarys contains serdexmethylphenidate, a prodrug of dexmethylphenidate, combined with immediate-release dexmethylphenidate. It is a central nervous system (CNS) stimulant prescribed for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. This medication may help improve attention and reduce impulsiveness and hyperactivity in individuals with ADHD.

Recommended Dosage:

Administration: Take the prescribed dosage orally once daily in the morning, with or without food. Azstarys capsules can be swallowed whole or opened, with the contents sprinkled into 50 mL of water or over 2 tablespoons of applesauce. Consume the mixture immediately or within 10 minutes; do not store it for future use.

Dosage for Pediatric Patients (6-12 Years):

Starting Dosage: 39.2 mg serdexmethylphenidate / 7.8 mg dexmethylphenidate once daily in the morning.

Adjustments: After one week, the dosage can be increased to 52.3 mg serdexmethylphenidate / 10.4 mg dexmethylphenidate per day, or decreased to 26.1 mg serdexmethylphenidate / 5.2 mg dexmethylphenidate daily, based on response and tolerability.

Maximum Dosage: 52.3 mg serdexmethylphenidate / 10.4 mg dexmethylphenidate once daily.

Dosage for Adults and Pediatric Patients (13-17 Years):

Starting Dosage: 39.2 mg serdexmethylphenidate / 7.8 mg dexmethylphenidate once daily in the morning.

Adjustments: After one week, the dosage can be increased to 52.3 mg serdexmethylphenidate / 10.4 mg dexmethylphenidate daily.

Maximum Dosage: 52.3 mg serdexmethylphenidate / 10.4 mg dexmethylphenidate once daily.

 

Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) may need to be continued over a long period. Regularly reassess the long-term use of Azstarys and adjust the dosage as necessary.